• Most Popular
  • Most Shared

UPDATE 2-Toyota denies in talks to cooperate with Daimler

Wed Jul 1, 2009 11:24pm EDT

Stocks

   

* Toyota: not considering making derivatives of Mercedes cars

* Magazine: plan would better utilise Toyota European plants (Updates with Toyota denial, changes dateline)

TOKYO, July 2 (Reuters) - Toyota Motor Corp (7203.T) denied on Thursday a report that it was considering building derivatives of Mercedes-Benz's (DAIGn.DE) A-Class and B-Class cars on its own platform to better utilise its European plants in the long term.

"We are denying this completely," Toyota spokesman Yuta Kaga said in Tokyo. "There is no truth to anything written in the article."

Citing sources at Toyota, German magazine auto motor und sport reported on Wednesday that the company was thinking about the generation of Mercedes compacts due to follow the upcoming version, which is scheduled to be introduced in 2011.

Typically, model lifecycle can last at least 6 years, so any production at a Toyota factory would not be likely until at least 2017.

According to the article, the two companies could also look at sharing development costs and even examine the possible joint production of Toyota's Lexus LS flagship luxury saloon and its Mercedes counterpart, the S-Class, the best-selling car in its segment.

Daimler called the report "speculation", declining to comment further. (Reporting by Christiaan Hetzner in FRANKFURT, Hendrik Sackmann in STUTTGART and Chang-Ran Kim in TOKYO; Editing by Michael Watson)



More from Reuters

Photo

Copenhagen climate talks in trouble, blame begins

COPENHAGEN (Reuters) - Prospects for a strong U.N. climate pact grew more remote on Thursday at the climax of two-year talks as ministers and leaders blamed leading emitters China and the United States for deadlock on carbon cuts. | Video

An office worker is reflected in the pavement as he walks with an umbrella in Singapore's financial district October 8, 2008.REUTERS/Vivek Prakash

Death of a salesman

Old-style sales reps may be fading thanks to a shift in the pharmaceutical market that has created a new gatekeeper in drug sales.  Full Article 

Marine from Delta Company of 2nd Light Armored Reconnaissance Battalion patrols near the town of Khan Neshin in Rig district of Helmand province, southern Afghanistan September 10, 2009. REUTERS/Goran Tomasevic

A bloody fight looms

Marines on the frontlines of the Afghan surge in Helmand Province are ramping up for a battle that their commander says will be the "end of the line" for insurgents.  Full Article